dokumendiregister.ee
OtsingAsutusedMCP
Otsing›Sotsiaalministeerium
Sissetulev kiriAvalik

Pöördumine

Sotsiaalministeerium · 4. november 2020
Viit
1.4-2/3164-1
Registreeritud
4. november 2020
Dokumendi liik
Sissetulev kiri
Adressaat
European Cancer Patient Coalition (ECPC)
Saabumis/saatmisviis
e-post
Funktsioon
1.4 EL otsustusprotsess ja rahvusvaheline koostöö
Sari
1.4-2 Rahvusvahelise koostöö korraldamisega seotud kirjavahetus (Arhiiviväärtuslik)
Toimik
1.4-2/2020
Vastutaja
Hanna Alajõe (Sotsiaalministeerium, Kantsleri vastutusvaldkond, Euroopa Liidu ja väliskoostöö osakond)
Lahendamise tähtaeg
4. detsember 2020

Failid

  • 📎E-kiri.pdf76 KB
  • 📎Factsheet National Legal framework on the right to be forgotten_Updated092020fin.pdf264 KB

Sisu (failidest)

Factsheet on the Right to be forgotten in the EU National Legislations Legal Background and current status from France, Belgium, Luxembourg and the Netherlands ▪ FRANCE Legal Ref.: Articles L. 1141-5 and L. 1141-6 French Public Health Code; Law no. 2016-41, 26 January 2016 - art. 190 (V); AERAS Convention. The provision on the right to be forgotten has been introduced in the French regulation in 2016, as part of the Law on the modernisation of the National Health System (Law no. 2016-41, 26 January 2016). Thanks to the reform, France endorsed the art. 190, now Article L1141-5. The rule states that in the context of insurance or loan contracts, the period beyond which no medical information relating to cancerous pathologies can be collected by insurer organisms may not exceed ten years after the date of the end of the treatment or, for cancerous pathologies occurring before age twenty-one, five years from the end of the therapeutic protocol. Indeed, in September 2020, French authorities adopted this extension for cancer patients, from eighteen years old to twenty-one. The terms and deadlines are updated regularly based on therapeutic progress and scientific data. The content of the provision needs to be integrated by the standards in the AERAS Convention and the other norms in the French Public Health Code (as L. 1141-2). The AERAS Convention (S'Assurer et Emprunter avec un Risque Aggravé de Santé/Insuring and Loaning with Aggravated Health Risk) represents a national protocol concluded between the State, the professional organizations representing the credit institutions, the finance companies, insurance companies, social security funding bodies and provident institutions as well as national organizations representing patients and users of the health system or representing disabled people. The Convention aims to facilitate access to insurance and loaning for people presenting an aggravated risk due to their state of health or a handicap with. It ensures that credit institutions and finance companies take full account of guarantees alternative to insurance, defining also specific procedures for informing applicants, investigating their files and mediating. The Convention applies, under certain conditions, to consumers, real estate and professional loan insurance. It fixes for mortgage loans (estate and professionals), the maximum amount to 320,000 euros and any condition of the loan duration is removed when the borrower is not more than 70 years old at the end of the loan. For consumer loans, the maximum amount of the loan granted without a health questionnaire is 17,000 euro. 1 A "reference table" incorporated into the AERAS (Obtaining Insurance and Credit with an Increased Health Risk agreement) defines, for each pathology, the period after which former patients can take out an insurance policy without any cover exclusions or having to pay an extra premium, under the same conditions as people who have not suffered from one of these illnesses. According to the law, the terms and time frames are regularly updated in line with advances in treatment and scientific data. A monitoring committee ensures the proper application of the provisions of this Convention and respect for the commitments of the parties. Alongside this organism, it has been established also a Committee for studies and researches, responsible for collecting and studying the available data on mortality and morbidity caused by the main pathologies. A mediation committee is in charge of the examination of the individual complaints by loan applicants. At the beginning of 2017, France adopted a new decree (Decree 2017-147 of 7 February 2017) to implement the obligation of information for insurers. By law, the insurer is responsible for giving an “information document on the right to be forgotten” to applicants for credit repayment insurance, at the same time as the normal risk declaration form. The regulation has been implemented by the Decree no. 2017-173 of 13 February 2017, that relates to the penalties applicable to any insurers that do not conform to the legal time limit for the collection of medical information. Since July 2019, kidney cancer, leukaemia, prostate cancer, cystic fibrosis and hepatitis C are among the new types of pathologies included in the referred table of the AERAS Convention. These measures have been pursued in 2020. ▪ BELGIUM Legal Ref. : Law no. C − 2019/40839, 4 April 2019. Promulgated in April 2019 and entered in force in February 2020, the Law modified the Insurance regulation (Loi relative aux assurance, C − 2014/11239, 4 Avril 2014) and reformed the article 61. The provisions are applicable to insurance contracts concerning mortgage and professional loans. The new provisions in article 61/1 and 61/2 introduced the interdiction for insurance companies to take into account previous cancer pathologies after 10 years from the end of the successful treatment and the absence of relapse within the same period. It is considered a successful treatment the period from the end of the active treatment and the absence of a new manifestation of the pathology. In May 2019, according to the provisions in article 61/3, the regulation has been implemented through the adoption of a reference table (Doc. No. C − 2019/12990). It determined a reduced time limit to access to the right to be forgotten for specific cancer pathologies. 2 Every two years, the Belgian Health Care Knowledge Centre (KCE) assesses the reference table based on the medical progress and the available scientific data relating to the pathologies referred. The Belgian monitoring office of pricing (Bureau du suivi de la tarification) is in charge of the disputes relating to the application of the concerned provisions. The Belgian regulation does not provide a limitation related to the amount covered by loans or insurance contracts. ▪ LUXEMBOURG Legal Ref.: Convention « Droit à l’oubli » - S’assurer et emprunter avec un risque de santé aggravé en raison d’une pathologie cancéreuse ou d’une infection virale à l’hépatite C ou d’une infection par le VIH Since the 1st January 2020, Luxembourg has introduced the “right to be forgotten” to facilitate insurance access for cancer survivors. The initiative has been formalized through a Convention between Luxembourg’s Ministry of Health, the Luxembourg Insurance and Reinsurance Association (ACA) and eight insurance companies. The Convention applies only and exclusively to the balance outstanding insurance for a loan or estate loans for the acquisition of the main residence or professional facilities and whose maximum amount does not exceed 1,000,000 euros. It does not apply to the acquisition of a second home or rental investments. For the same person concerned, it applies only within the limit of the maximum amount of 1,000,000 euros of cover. According to the provisions of this Convention, the applicant cured of cancer is entitled not to declare his pathology when the therapeutic protocol relating to this cancerous pathology has ended for 10 years (end of active treatment of cancer by surgery, radiotherapy, chemotherapy); or the therapeutic protocol relating to this cancerous pathology has ended for 5 years, for cancer diagnosed before the age of 18. During the mentioned timeframe, the absence of relapse is needed. Apart from this specific condition, the right to be forgotten is supplemented by some exceptions, related to the Right to be forgotten with the obligation to declare, without additional premium. When applying for balance outstanding insurance for a mortgage loan, the applicant cured of specific cancers (10 specific types of cancer) or viral hepatitis C, must declare his pathology, but if certain conditions are met, the insurer cannot exclude the insurance candidate or request a premium. The Convention provides the establishment of a monitoring committee, made by experts, to ensure its proper application of the provisions and the respect of the commitments of the parties. For this, it has the competence to examine the individual complaints addressed to it by the applicants. 3 ▪ THE NETHERLANDS Press release from the Minister of Finance: Ex-cancer patients can better insure themselves (10 July 2020) The Netherlands announced an ongoing legislative process on the Right to be forgotten. On July 10th,2020, Minister Hoekstra announced that the Council of Ministers approved the ‘clean-slate policy’ conducing to the implementation of the Right to be forgotten by January 2021 at the latest. According to what has been communicated the provision will apply to death insurance policy (ORV) and funeral insurance policy. To qualify for the clean-slate policy, a cancer survivor has to be in complete remission from cancer for 10 years. This period is reduced to five years for those who were younger than 21 when they were diagnosed with the disease. The policy is based on the model that has been in force in France. As for this latter, the provision will be complemented with a list of exceptions to identify the cancers that qualify for a period of less than 10 years. This table will include the most common cancers affecting the 18 to 39 age group such as ovarian, testicle, skin, and breast cancers, and certain types of blood cancer. 4 Annex Reference Table (updated June 2020)* *The document contains the common cancer pathologies included into the three regulations with shorter delays than 10 years Type of Pathology Histological types and Access time from the end stages - of active treatment of pre-therapeutic stages cancer pathology and without relapse TESTICULAR CANCER Pure seminoma, stage I 3 years Pure seminoma, stage II 6 years Non-seminomatous tumours or mixed, stage I and II 6 years BREAST CANCERS Ductal Carcinoma in situ (IN SITU) 1 year Locular Carcinoma in situ MELANOMA OF SKIN Melanoma in situ or Level Clark I Complete exeresis 1 year Absence of dysplastic nevus syndrome CERVICAL CANCER CIN III (or HSIL) or in situ 1 year KIDNEY CANCER Renal cell carcinoma (RCC) 8 years of clear cell morphology, diagnosed after the age of 50 years, T1N0M0 level of the Fuhrman grade classification I and II 5 Chromophobe renal cell 5 years carcinoma, T1N0M0 level COLON AND RECTAL CANCER Stage Tis (stage 0): - Diagnosed after the age of 1 years 50 years old Stage I: T1N0M0: - diagnosed after the age of 50 years 2 years - histologic type: adenocarcinoma Stage I: T2N0M0: - Diagnosed after the age of 8 years 50 years - Histologic type: adenocarcinoma THYROID CANCER Papillary/Vesicular <45 year at the diagnosis, stage I 3 years Papillary/ vesicular 45 or 3 years older at diagnosis, stage I or II 6 years Papillary/vesicular, stage III HODGKIN'S LYMPHOMA Hodgkin’s lymphoma stage 6 years / 8 years (for 1A after a post-treatment Luxembourg) follow-up Hodgkin’s lymphoma stage 1B and 2A after post- 8 years / 10 years (for treatment follow-up Luxembourg) ACUTE PROMYELOCYTIC Regardless of the number of LEUKAEMIA/ LAP/ LAM3 leukocytes at diagnosis 3 years / 5 (for Luxembourg) Treatment performed 6 Saatja: Grazia Scocca <[email protected]> Saadetud: 04.11.2020 13:39 Adressaat: SM Info <[email protected]> Teema: Request for information - Access to financial instruments Cancer Survivors &nbsp; Dear Madam, Sir, &nbsp; I hope my messages finds you well and safe in this difficult time. &nbsp; My name is Grazia Scocca, I am a legal researcher for the European Cancer Patient Coalition (ECPC), based in Brussels. &nbsp; I am addressing you this email, because I am working on a research study on the access to financial services for cancer survivors. The research is conducted under the supervision of Dr. Françoise Meunier, oncologist, member of the Scientific Committee of the ECPC and Vice President of the Federation of the European Academies of Medicine (FEAM). &nbsp; The aim of the research project is to assess the level of accessibility for cancer survivors to financial services, once their treatments end. The research takes into consideration the promulgation of legal provisions in France, Belgium and Luxembourg on the right to be forgotten for cancer survivors. The above-mentioned initiatives introduced for cancer survivors the Right to not declare their cancer (10 years after the end of the active treatment and 5 years for cancers under 18 or 21) when they apply for loans, mortgages, insurances or other financial services. &nbsp; Rely on your competence on cancer care and survivorship,&nbsp;I would like to ask you if to apply for a mortgage, loans or life insurance in Estonia, customers/former patients have to provide information about your health status and past diseases. And also, if to apply for mortgages and loans, a life Insurance contract is mandatory. &nbsp; I hope you could help me providing more information about the regulation and the practice to access to those financial instruments. My sincere appreciation for any sort of feedback you can provide me on the topic. Please also, feel free to put me in contact with any other office in your Country which is in charge of this issue. &nbsp; In addition, I attach to this email a document containing the English summary of the laws passed in France, Belgium and Luxembourg. I remain at your disposal for any additional information relating to the project. &nbsp; Yours faithfully, &nbsp; &nbsp; Grazia Scocca &nbsp; &nbsp; Grazia Scocca Legal Specialist PhD, J.D. &nbsp;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; +32 (0) 2 342 01 04&nbsp; &nbsp; &nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;
Allikas: Sotsiaalministeerium dokumendiregister →
dokumendiregister.eeAsutusedEesti avalike dokumendiregistrite otsing · nimistu.ee andmetel